DCPrime
DCPrime is a clinical stage company which develops novel cancer immunotherapies based on its DCOne platform technology.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed DCPrime Information
Geographic Data
Address:
City: Leiden
State: Zuid-Holland
Zip:
Country: The Netherlands
Financial Info
Stage:
series unknown
Raised Last:
$19M
Raised Total:$27M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
DCPrime is a clinical-stage cancer immunotherapy company, which develops therapeutic vaccines based on its proprietary DCOne platform. DCOne‐based vaccines share all immune‐stimulatory properties with patient-derived dendritic cell‐based vaccines, and have the simple logistics of off‐the‐shelf products. DCOne cells express a range of known tumor antigens, which are targeted in several cancer types.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2014 | Corporate Round | - |
SkylineDx Van Herk Ventures SkylineDx Van Herk Ventures |
3/2009 | Venture Round | 1 | - |
Thuja Capital Thuja Capital |
3/2018 | Venture Round | 1 | $18.7M |
Van Herk Ventures Van Herk Ventures |
1/2016 | Grant | 1 | $6.5M |
Horizon 2020 Horizon 2020 |
7/2015 | Debt Financing | $1.3M | 10/2014 | Corporate Round | 2 | - |
SkylineDx Van Herk Ventures SkylineDx Van Herk Ventures |
3/2009 | Venture Round | 1 | - |
Thuja Capital Thuja Capital |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
